Mounjaro Benefits vs Alternatives | Cured Pharmacy UK

Clinically Proven UK Registered Pharmacy

Cheapest Mounjaro Benefits vs Alternatives - UK Price

Compare Mounjaro to weight loss alternatives at the cheapest UK price from £124.99 plus £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off first order using code WEIGHTLOSSNEW

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Compare Mounjaro Benefits Against Other Options

Published on: June 03, 2026

Understanding mounjaro benefits vs alternatives UK is essential when choosing the right weight loss treatment for your health goals. As a UK-registered pharmacy with thousands of patient consultations completed, we've seen firsthand how tirzepatide's dual-action mechanism delivers clinical outcomes that differ significantly from single-pathway treatments like semaglutide and liraglutide.

How Mounjaro's Dual Mechanism Differs From Single GLP-1 Treatments

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike Wegovy (semaglutide) and Saxenda (liraglutide), which activate only GLP-1 receptors, tirzepatide simultaneously targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual activation enhances insulin secretion, suppresses glucagon release more effectively, and produces greater appetite reduction than single-pathway alternatives [1].

In the SURPASS-2 head-to-head trial comparing tirzepatide directly against semaglutide 1mg, patients receiving the highest tirzepatide dose (15mg) achieved an average 12.4kg weight reduction versus 6.2kg with semaglutide over 40 weeks — nearly double the effect [2]. This superior efficacy stems from GIP's additional metabolic actions, including enhanced fat oxidation and improved insulin sensitivity beyond what GLP-1 activation alone provides.

Mounjaro vs Wegovy: Clinical Trial Data Comparison

Both Mounjaro and Wegovy represent significant advances in pharmacological weight management, but their clinical profiles reveal important differences. The SURMOUNT-1 trial demonstrated that tirzepatide 15mg produced an average 22.5% total body weight reduction over 72 weeks in adults with obesity [1]. By comparison, the STEP-1 trial of semaglutide 2.4mg (Wegovy's active ingredient) showed an average 14.9% weight reduction over 68 weeks [3].

Tolerability profiles differ slightly between the two medications. In our clinical experience at Cured Pharmacy, patients report similar gastrointestinal side effects — primarily nausea, diarrhoea, and constipation — with both treatments during dose escalation. However, tirzepatide's dual mechanism may offer metabolic advantages beyond weight loss, including greater improvements in glycaemic control markers even in non-diabetic patients [2].

Dosing convenience remains identical: both require once-weekly subcutaneous injection using pre-filled pens. Wegovy follows a fixed escalation schedule from 0.25mg to 2.4mg, while Mounjaro escalates from 2.5mg to a maximum of 15mg. Your UK prescriber will determine the appropriate starting dose and titration schedule based on your individual response and tolerability during your clinical assessment.

Which Patients Benefit Most From Tirzepatide

Clinical evidence suggests tirzepatide may be particularly beneficial for patients who haven't achieved adequate weight loss with single GLP-1 agonists, those with higher baseline BMI (≥35 kg/m²), or individuals with concurrent metabolic conditions requiring robust glycaemic control [1][2]. However, both medications require prescription assessment by a UK-registered clinician, who will evaluate your complete medical history, current medications, and weight loss goals before recommending the most suitable treatment.

Mounjaro Compared to Daily Injectable Saxenda

Saxenda contains liraglutide, an earlier-generation GLP-1 receptor agonist that requires daily subcutaneous injection rather than weekly dosing. In the SCALE Obesity and Prediabetes trial, liraglutide 3mg produced an average 8.4kg weight loss over 56 weeks — clinically significant but substantially less than the outcomes observed with newer weekly GLP-1 treatments [4].

The dosing frequency represents the most practical distinction between these medications. Patients often report that weekly injections with Mounjaro or Wegovy improve treatment adherence compared to Saxenda's daily regimen. From a pharmacokinetic perspective, liraglutide's shorter half-life necessitates daily administration, whereas tirzepatide's extended half-life of approximately 5 days maintains therapeutic drug levels throughout the week [1][4].

Cost considerations vary significantly. Saxenda starts from £135.00 at Cured Pharmacy, making it the most affordable injectable GLP-1 option, though the daily dosing requirement means you'll use more pens monthly than with weekly alternatives. Mounjaro starts from £124.99 reflecting its advanced dual-mechanism formulation and superior clinical efficacy in head-to-head comparisons. All pricing remains transparent before your consultation, with no hidden fees.

Transitioning Between GLP-1 Treatments

Patients sometimes switch from daily liraglutide to weekly tirzepatide or semaglutide due to convenience preferences or inadequate weight loss response. If you're currently using Saxenda and considering Mounjaro, your UK prescriber will create an appropriate transition plan, typically involving a washout period and starting at the lowest Mounjaro dose to minimise gastrointestinal side effects. Never adjust or switch prescription medications without clinical supervision.

Treatment Active Ingredient Mechanism Dosing Frequency Average Weight Loss* Starting Price
Mounjaro Tirzepatide Dual GIP/GLP-1 agonist Once weekly injection Up to 22.5% (72 weeks) From £124.99
Wegovy Semaglutide GLP-1 agonist Once weekly injection Up to 14.9% (68 weeks) From £69.00
Saxenda Liraglutide GLP-1 agonist Daily injection Up to 8% (56 weeks) From £68.00
Orlistat Orlistat Lipase inhibitor Three times daily oral ~3kg additional vs placebo (12 months) From £32.00
Xenical Orlistat 120mg Lipase inhibitor Three times daily oral ~3kg additional vs placebo (12 months) From £32.00

Mounjaro vs Oral Fat Absorption Blockers (Orlistat, Xenical)

Orlistat represents a fundamentally different mechanism of action from GLP-1 receptor agonists. Rather than affecting appetite-regulating hormones, orlistat inhibits pancreatic and gastric lipases, preventing approximately 30% of dietary fat absorption in the gastrointestinal tract [5]. This unabsorbed fat is excreted, which can cause distinctive gastrointestinal side effects including oily stools, flatulence, and faecal urgency — particularly when consuming high-fat meals.

Clinical efficacy differs substantially. Meta-analyses of orlistat trials show an average 2.9kg additional weight loss compared to placebo over 12 months when combined with dietary modification [5]. By contrast, tirzepatide produces 15-20kg average reductions in clinical trials, though direct comparison is complicated by differences in study populations and baseline characteristics [1][5].

Orlistat's primary advantage lies in its oral administration and significantly lower cost — starting from £135.00 at Cured Pharmacy for generic formulations. It's often considered for patients with lower BMI thresholds (28-30 kg/m² with comorbidities) who may not meet prescribing criteria for GLP-1 treatments, or those preferring non-injectable options despite more modest expected outcomes. Xenical is simply the branded version of orlistat 120mg, with identical active ingredients and efficacy.

Understanding the Mounjaro Benefits vs Alternatives UK: Side Effect Profiles

All weight loss medications carry potential side effects, and understanding these profiles helps inform treatment selection. GLP-1 receptor agonists including Mounjaro, Wegovy, and Saxenda share common gastrointestinal effects: nausea (reported in 20-44% of patients), diarrhoea (15-30%), constipation (15-24%), and vomiting (9-24%) during dose escalation [1][3][4]. These effects typically diminish after 4-8 weeks as your body adapts to the medication.

Tirzepatide's dual GIP/GLP-1 activation doesn't appear to increase gastrointestinal side effects compared to semaglutide alone, despite its greater efficacy. In SURPASS-2, discontinuation rates due to adverse events were similar between tirzepatide and semaglutide groups (4-7% across doses) [2]. Slower dose titration, taking injections with food, and staying well-hydrated can minimise these effects regardless of which GLP-1 treatment you use.

Orlistat produces distinctly different side effects related to its fat-blocking mechanism. Approximately 15-30% of patients experience oily spotting, flatulence with discharge, or faecal urgency [5]. These effects are directly proportional to dietary fat intake and can be managed by adhering to a lower-fat diet (≤30% of calories from fat). Unlike GLP-1 treatments, orlistat doesn't cause nausea or affect gastric emptying.

Rare but Serious Adverse Events

GLP-1 receptor agonists carry warnings for potential thyroid C-cell tumours based on rodent studies, though no causal relationship has been established in humans [1][3]. They're contraindicated in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Acute pancreatitis, gallbladder disease, and hypoglycaemia (particularly when combined with other glucose-lowering medications) represent other rare but important risks your prescriber will discuss during assessment. All prescription medications dispensed by Cured Pharmacy include comprehensive patient information leaflets detailing complete safety profiles.

Choosing the Right Weight Loss Treatment: Clinical Decision Factors

Your UK prescriber considers multiple factors when recommending between Mounjaro and alternative treatments: baseline BMI, previous weight loss attempts, comorbid conditions (type 2 diabetes, hypertension, sleep apnoea), contraindications, personal preferences regarding injection frequency, and realistic weight loss goals. Patients with BMI ≥30 kg/m² (or ≥27 kg/m² with weight-related comorbidities) typically qualify for GLP-1 treatments, while those with lower BMI may be considered for orlistat [1][5].

Cost represents a legitimate consideration in treatment selection. At Cured Pharmacy, Mounjaro starts from £124.99 Wegovy from £135.00 Saxenda from £135.00 and Orlistat from £135.00. These transparent prices are displayed before your consultation, allowing you to make informed decisions without surprise fees. While tirzepatide offers superior clinical efficacy, semaglutide and liraglutide remain highly effective evidence-based options that may better suit your budget and clinical needs.

No weight loss medication works in isolation. All treatments licensed in the UK — whether Mounjaro, Wegovy, Saxenda, or orlistat — are indicated as adjuncts to reduced-calorie diet and increased physical activity [1][3][4][5]. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team provide ongoing support throughout your treatment journey, but sustainable weight management requires comprehensive lifestyle modification alongside pharmacological intervention. Your prescriber will discuss realistic expectations and long-term maintenance strategies during your clinical assessment.

Starting Your Weight Loss Treatment at Cured Pharmacy

Beginning treatment takes under 3 minutes with our online clinical assessment. You'll answer questions about your medical history, current medications, and weight loss goals. A UK-registered prescriber reviews your assessment, and if appropriate, issues a prescription dispensed by our GPhC-registered pharmacy (9012511). We offer discreet packaging and delivery across the UK, with all genuine UK-licensed medications. Whether you proceed with Mounjaro or an alternative treatment, you'll receive comprehensive dosing instructions, injection technique guidance (for injectable treatments), and ongoing clinical support throughout your weight management journey.

Scientific References

  1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  2. Frías, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2): a randomised, open-label, parallel-group, multicentre, phase 3 trial. The Lancet, 398(10295), 64–77. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
  3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  4. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
  5. Rucker, D., et al. (2007). Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ, 335(7631), 1194–1199. https://doi.org/10.1136/bmj.39385.413113.25 [accessed 13 August 2026]
  6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to reduced-calorie diet and increased physical activity alongside pharmacological treatment.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What are the main mounjaro benefits vs alternatives UK patients should know?
Mounjaro's dual GIP/GLP-1 mechanism produces superior weight loss (average 22.5% in trials) compared to single GLP-1 treatments like Wegovy (14.9%) and Saxenda (8%), with once-weekly dosing convenience. However, all treatments require prescription assessment and work best alongside diet and exercise modifications.
Is Mounjaro more effective than Wegovy for weight loss?
Clinical trials suggest yes — SURPASS-2 showed tirzepatide produced nearly double the weight reduction of semaglutide 1mg over 40 weeks. However, individual response varies, and your UK prescriber will recommend the most appropriate treatment based on your complete medical assessment.
Can I switch from Saxenda to Mounjaro if I'm not losing enough weight?
Potentially, yes. Patients with inadequate response to daily liraglutide sometimes transition to weekly tirzepatide under clinical supervision. Your prescriber will create an appropriate transition plan including washout period and dose titration to minimise side effects.
Why is Mounjaro more expensive than other weight loss treatments?
Mounjaro's higher cost reflects its advanced dual-receptor mechanism, superior clinical efficacy in head-to-head trials, and newer patent-protected formulation. Wegovy, Saxenda, and orlistat offer more affordable alternatives with proven efficacy, though typically producing more modest weight reductions.
Do Mounjaro and Wegovy cause the same side effects?
Both cause similar gastrointestinal effects (nausea, diarrhoea, constipation) during dose escalation, affecting 20-44% of patients. Discontinuation rates due to side effects are comparable (4-7%), and symptoms typically improve after 4-8 weeks as your body adapts to treatment.
Is orlistat a good alternative if I can't afford GLP-1 injections?
Orlistat provides a more affordable option starting from £135.00 though clinical trials show more modest weight loss (~3kg additional vs placebo) compared to GLP-1 treatments. It's suitable for patients with lower BMI thresholds or those preferring oral medication despite different side effect profiles.
How quickly will I see mounjaro benefits compared to alternatives?
Most patients notice appetite reduction within 1-2 weeks of starting tirzepatide, with measurable weight loss by week 4. Wegovy and Saxenda follow similar timelines. Maximum effects typically occur after 4-6 months of treatment at maintenance doses, though individual response varies considerably.
Do I need a prescription for Mounjaro and other weight loss injections in the UK?
Yes — Mounjaro, Wegovy, and Saxenda are prescription-only medicines in the UK requiring clinical assessment by a registered prescriber. Cured Pharmacy provides free online consultation (under 3 minutes) with UK-registered clinicians who evaluate your suitability before prescribing any weight loss medication.
How does Mounjaro compare to Saxenda for weight loss results?
Clinical trials show Mounjaro achieves greater average weight loss than Saxenda, with patients losing 15-22% of body weight versus 5-10% with Saxenda. Cured Pharmacy provides both options with full prescriber consultations to help you choose the most suitable treatment based on your health goals and medical history.
What are the benefits of choosing Mounjaro over Wegovy in the UK?
Mounjaro contains tirzepatide which targets both GIP and GLP-1 receptors, while Wegovy targets GLP-1 only, often resulting in superior weight loss outcomes. Cured Pharmacy offers transparent pricing on both medications and can help you compare benefits versus alternatives during your online consultation to find the best fit.
Is Mounjaro more expensive than other weight loss injections?
Mounjaro prices vary by dose starting from £124.99 at Cured Pharmacy, which is competitive when comparing benefits versus alternatives like Wegovy or Saxenda. While initial costs may be higher than some alternatives, many patients find the enhanced weight loss results justify the investment for long-term health benefits.
Can I switch from Ozempic to Mounjaro through Cured Pharmacy?
Yes, you can switch from Ozempic to Mounjaro after a prescriber consultation at Cured Pharmacy to assess suitability. Many patients switch to access Mounjaro's dual-action mechanism and potentially improved weight loss outcomes compared to Ozempic's single GLP-1 receptor targeting.
Does Mounjaro work faster than other weight loss alternatives available in the UK?
Mounjaro users typically see initial weight loss within the first 4 weeks, similar to other GLP-1 medications, but greater overall results by 12-16 weeks. Cured Pharmacy provides ongoing support and dose adjustments to optimise your results when comparing Mounjaro benefits versus alternatives throughout your treatment journey.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.